{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:05:11Z","timestamp":1784761511281,"version":"3.55.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-15-P-0034"],"award-info":[{"award-number":["HDTRA1-15-P-0034"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R43AI120260-01"],"award-info":[{"award-number":["1R43AI120260-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0228006","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T13:33:26Z","timestamp":1580391206000},"page":"e0228006","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["A novel gamma radiation-inactivated sabin-based polio vaccine"],"prefix":"10.1371","volume":"15","author":[{"given":"Gregory J.","family":"Tobin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena K.","family":"Gaidamakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taralyn J.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth V.","family":"Bushnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera Y.","family":"Matrosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1712-3811","authenticated-orcid":true,"given":"Stephen J.","family":"Dollery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather N.","family":"Meeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kouiavskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Chumakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"issue":"4","key":"pone.0228006.ref001","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.idc.2015.07.003","article-title":"The Challenge of Global Poliomyelitis Eradication","volume":"29","author":"JR Garon","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"pone.0228006.ref002","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/14760584.2015.1001750","article-title":"Polio endgame: the global introduction of inactivated polio vaccine","volume":"14","author":"M Patel","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"pone.0228006.ref003","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0950268816002569","article-title":"Wild and vaccine-derived poliovirus circulation, and implications for polio eradication","volume":"145","author":"PL Lopalco","year":"2017","journal-title":"Epidemiol Infect"},{"key":"pone.0228006.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-3292-4_1","article-title":"An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication","volume":"1387","author":"PD Minor","year":"2016","journal-title":"Methods Mol Biol"},{"key":"pone.0228006.ref005","first-page":"75","article-title":"Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies","volume":"105","author":"P. Minor","year":"2001","journal-title":"Dev Biol (Basel)"},{"issue":"1","key":"pone.0228006.ref006","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jmv.20250","article-title":"Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains","volume":"75","author":"PD Minor","year":"2005","journal-title":"J Med Virol"},{"issue":"6","key":"pone.0228006.ref007","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/14760584.2016.1140041","article-title":"Polio endgame: the global switch from tOPV to bOPV","volume":"15","author":"J Garon","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"pone.0228006.ref008","unstructured":"Two out of three wild poliovirus strains eradicated WHO website: World Health Organization; 2019 [cited 2019 10\/29\/2019]. Available from: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/two-out-of-three-wild-poliovirus-strains-eradicated."},{"key":"pone.0228006.ref009","unstructured":"Global Polio Iradication Initiative. Polio Eradication & EndgameStrategic Plan 2013\u20132018. 2013."},{"issue":"Suppl","key":"pone.0228006.ref010","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1093\/infdis\/jiu128","article-title":"Affordable inactivated poliovirus vaccine: strategies and progress","volume":"2101","author":"H Okayasu","year":"2014","journal-title":"J Infect Dis"},{"key":"pone.0228006.ref011","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1749-6632.1960.tb40933.x","article-title":"A review of theoretical, experimental, and practical considerations in the use of formaldehyde for the inactivation of poliovirus","volume":"83","author":"JE Salk","year":"1960","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"pone.0228006.ref012","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4269\/ajtmh.1999.60.441","article-title":"Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks","volume":"60","author":"SC Weaver","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"pone.0228006.ref013","first-page":"109","article-title":"The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. 1963","volume":"142","author":"N Nathanson","year":"1995","journal-title":"Am J Epidemiol"},{"key":"pone.0228006.ref014","first-page":"103","article-title":"Review of accidents caused by incomplete inactivation of viruses","volume":"81","author":"F. Brown","year":"1993","journal-title":"Dev Biol Stand"},{"issue":"993","key":"pone.0228006.ref015","first-page":"1","article-title":"WHO Expert Committee on Biological Standardization. Sixty-fifth report (Annex 3)","author":"WH Organization","year":"2015","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"suppl_1","key":"pone.0228006.ref016","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/infdis\/jiw550","article-title":"A Supply and Demand Management Perspective on the Accelerated Global Introductions of Inactivated Poliovirus Vaccine in a Constrained Supply Market","volume":"216","author":"I Lewis","year":"2017","journal-title":"J Infect Dis"},{"key":"pone.0228006.ref017","unstructured":"Global Polio Eradication Initiative. Affordable IPV: Developing affordable inactivated polio vaccine. 2019. Available from: http:\/\/polioeradication.org\/tools-and-library\/current-research-areas\/affordable-ipv\/."},{"issue":"15\u201316","key":"pone.0228006.ref018","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0264-410X(98)00409-5","article-title":"Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains","volume":"17","author":"G Kersten","year":"1999","journal-title":"Vaccine"},{"issue":"41","key":"pone.0228006.ref019","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1016\/j.vaccine.2007.07.060","article-title":"Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains","volume":"25","author":"Y Tano","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"pone.0228006.ref020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chom.2012.05.011","article-title":"Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio- protective Mn2+-Peptide complex from Deinococcus","volume":"12","author":"EK Gaidamakova","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"9","key":"pone.0228006.ref021","doi-asserted-by":"crossref","first-page":"e12570","DOI":"10.1371\/journal.pone.0012570","article-title":"Small-molecule antioxidant proteome-shields in Deinococcus radiodurans","volume":"5","author":"MJ Daly","year":"2010","journal-title":"PloS ONE"},{"issue":"29","key":"pone.0228006.ref022","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.vaccine.2017.05.016","article-title":"Deinococcus Mn(2+)-peptide complex: A novel approach to alphavirus vaccine development","volume":"35","author":"M Gayen","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"pone.0228006.ref023","first-page":"571","article-title":"Return of inactivated whole-virus vaccine for superior efficacy. \u200eImmunol","volume":"90","author":"Y. Furuya","year":"2012","journal-title":"Cell Biol"},{"key":"pone.0228006.ref024","unstructured":"FDA. Food Irradiation. Available at: http:\/\/wwwfdagov\/Food\/ResourcesForYou\/Consumers\/ucm261680htm. 2016."},{"issue":"2","key":"pone.0228006.ref025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7774\/cevr.2015.4.2.145","article-title":"Application of radiation technology in vaccines development","volume":"4","author":"HS Seo","year":"2015","journal-title":"Clin Exp Vaccine Res"},{"issue":"3","key":"pone.0228006.ref026","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrmicro2073","article-title":"A new perspective on radiation resistance based on Deinococcus radiodurans","volume":"7","author":"MJ Daly","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"pone.0228006.ref027","article-title":"Pan-viral serology implicates enteroviruses in acute flaccid myelitis","author":"RD Schubert","year":"2019","journal-title":"Nat Med"},{"issue":"4","key":"pone.0228006.ref028","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"G. K\u00e4rber","year":"1931","journal-title":"Pathol u Pharmakol"},{"key":"pone.0228006.ref029","first-page":"227","article-title":"The Method of Right and Wrong Cases ('Constant Stimuli') Without Gauss's Formulae","volume":"2","author":"C. Spearman","year":"1908","journal-title":"Br J Psychol"},{"key":"pone.0228006.ref030","author":"H Kangro","year":"1996"},{"issue":"1","key":"pone.0228006.ref031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2004.11.003","article-title":"Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV)","volume":"33","author":"G Rezapkin","year":"2005","journal-title":"Biologicals"},{"issue":"21","key":"pone.0228006.ref032","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.vaccine.2018.04.024","article-title":"A comparative study between outbred and inbred rat strains for the use in in vivo IPV potency testing","volume":"36","author":"V Bockstal","year":"2018","journal-title":"Vaccine"},{"key":"pone.0228006.ref033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4939-1571-2_5","article-title":"Growth of human rhinovirus in H1-HeLa cell suspension culture and purification of virions","volume":"1221","author":"WM Lee","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"3","key":"pone.0228006.ref034","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2144\/00283rr01","article-title":"Assessment of RNA quality by semi-quantitative RT-PCR of multiple regions of a long ubiquitous mRNA","volume":"28","author":"GH Swift","year":"2000","journal-title":"BioTechniques"},{"key":"pone.0228006.ref035","first-page":"119","article-title":"Potency testing of killed polio vaccine in rats","volume":"47","author":"G van Steenis","year":"1981","journal-title":"Dev Biol Stand"},{"key":"pone.0228006.ref036","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinorgbio.2016.08.012","article-title":"Manganese binding to antioxidant peptides involved in extreme radiation resistance in Deinococcus radiodurans","volume":"164","author":"M Peana","year":"2016","journal-title":"J Inorg Biochem"},{"issue":"11","key":"pone.0228006.ref037","first-page":"30169","article-title":"Risk assessment, risk management and risk-based monitoring following a reported accidental release of poliovirus in Belgium","volume":"21","author":"E Duizer","year":"2016","journal-title":"September to November"},{"key":"pone.0228006.ref038","author":"E Vidor","year":"2012"},{"issue":"1","key":"pone.0228006.ref039","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2004.11.001","article-title":"Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method","volume":"33","author":"G Rezapkin","year":"2005","journal-title":"Biologicals"},{"key":"pone.0228006.ref040","unstructured":"Food and Drug Administration. Food Irradiation: What You Need to Know: 2016. Available from: https:\/\/www.fda.gov\/food\/buy-store-serve-safe-food\/food-irradiation-what-you-need-know."},{"key":"pone.0228006.ref041","first-page":"97","article-title":"Factors affecting the stability of viral vaccines","volume":"87","author":"J. Peetermans","year":"1996","journal-title":"Dev Biol Stand"},{"issue":"4","key":"pone.0228006.ref042","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.vaccine.2009.10.126","article-title":"Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB","volume":"28","author":"SS Martin","year":"2010","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T13:33:51Z","timestamp":1580391231000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228006"}},"subtitle":[],"editor":[{"given":"Mohammed","family":"Alsharifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0228006","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]}}}